Rodgers Brothers’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-3,100
| Closed | -$234K | – | 251 |
|
|
2026
Q1 | $234K | Sell |
3,100
-3,900
| -56% | -$293K | 0.03% | 229 |
|
|
2025
Q4 | $521K | Sell |
7,000
-87,955
| -93% | -$6.43M | 0.06% | 178 |
|
|
2025
Q3 | $6.41M | Sell |
94,955
-7,646
| -7% | -$508K | 0.79% | 36 |
|
|
2025
Q2 | $6.69M | Sell |
102,601
-1,845
| -2% | -$111K | 0.84% | 33 |
|
|
2025
Q1 | $6.45M | Sell |
104,446
-650
| -0.6% | -$43.1K | 0.86% | 30 |
|
|
2024
Q4 | $7.58M | Buy |
105,096
+2,315
| +2% | +$181K | 0.99% | 25 |
|
|
2024
Q3 | $8.37M | Sell |
102,781
-175
| -0.2% | -$14K | 1.06% | 24 |
|
|
2024
Q2 | $7.64M | Sell |
102,956
-1,287
| -1% | -$96.5K | 1.04% | 24 |
|
|
2024
Q1 | $8.13M | Buy |
104,243
+3,645
| +4% | +$271K | 1.11% | 19 |
|
|
2023
Q4 | $7.19M | Sell |
100,598
-725
| -0.7% | -$50.5K | 1.13% | 19 |
|
|
2023
Q3 | $7.03M | Buy |
101,323
+7,375
| +8% | +$557K | 1.2% | 16 |
|
|
2023
Q2 | $7.61M | Buy |
93,948
+4,938
| +6% | +$404K | 1.34% | 15 |
|
|
2023
Q1 | $7.18M | Buy |
89,010
+500
| +0.6% | +$40.3K | 1.38% | 16 |
|
|
2022
Q4 | $6.62M | Sell |
88,510
-125
| -0.1% | -$8.9K | 1.33% | 17 |
|
|
2022
Q3 | $5.72M | Buy |
88,635
+250
| +0.3% | +$17.3K | 1.22% | 23 |
|
|
2022
Q2 | $6.13M | Buy |
88,385
+2,000
| +2% | +$148K | 1.21% | 22 |
|
|
2022
Q1 | $6.64M | Sell |
86,385
-100
| -0.1% | -$7.19K | 1.19% | 24 |
|
|
2021
Q4 | $6.62M | Sell |
86,485
-1,000
| -1% | -$73.5K | 1.18% | 24 |
|
|
2021
Q3 | $6.46M | Sell |
87,485
-12,500
| -13% | -$937K | 1.29% | 22 |
|
|
2021
Q2 | $6.67M | Buy |
99,985
+16,725
| +20% | +$1.12M | 1.28% | 22 |
|
|
2021
Q1 | $6.19M | Buy |
83,260
+57,840
| +228% | +$4.39M | 1.28% | 22 |
|
|
2020
Q4 | $1.85M | Sell |
25,420
-75
| -0.3% | -$5.29K | 0.42% | 68 |
|
|
2020
Q3 | $1.7M | Buy |
25,495
+11,770
| +86% | +$745K | 0.44% | 61 |
|
|
2020
Q2 | $782K | Hold |
13,725
| – | – | 0.21% | 108 |
|
|
2020
Q1 | $482K | Buy |
13,725
+3,625
| +36% | +$173K | 0.15% | 128 |
|
|
2019
Q4 | $527K | Hold |
10,100
| – | – | 0.14% | 131 |
|
|
2019
Q3 | $510K | Hold |
10,100
| – | – | 0.14% | 132 |
|
|
2019
Q2 | $485K | Buy |
10,100
+1,000
| +11% | +$46.2K | 0.13% | 141 |
|
|
2019
Q1 | $440K | Buy |
9,100
+750
| +9% | +$33.8K | 0.13% | 143 |
|
|
2018
Q4 | $343K | Buy |
+8,350
| New | +$343K | 0.11% | 144 |
|
Other funds holding HOLX
Rodgers Brothers's HOLX Position: Q2 2026 in Review
Rodgers Brothers sold out of Hologic (HOLX) in Q2 2026, closing a stake of 3,100 shares — an estimated $234K sold.
Rodgers Brothers first reported a position in HOLX in Q4 2018 and held it in 30 quarters. The position peaked at $8.37M in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Rodgers Brothers reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Rodgers Brothers sold 3,100 Hologic shares in Q2 2026, an estimated $234K.
- Rodgers Brothers first reported a position in Hologic in Q4 2018 and held it in 30 quarters.
- Rodgers Brothers's Hologic position peaked at $8.37M in Q3 2024.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Rodgers Brothers's 13F filing for Q2 2026, filed 5 Aug 2026.